How to Help Your Patients Find Myfembree in Stock

As a prescriber of Myfembree (Relugolix 40 mg / Estradiol 1 mg / Norethindrone Acetate 0.5 mg), you've likely heard from patients who can't fill their prescription at a local pharmacy. While Myfembree is not in formal shortage, its status as a high-cost specialty medication means that many retail pharmacies simply don't stock it.

This guide provides a practical, step-by-step approach to help your patients access Myfembree with minimal delays and frustration.

Current Availability Overview

Myfembree is manufactured by Myovant Sciences in collaboration with Pfizer and is available as both the brand-name product and a generic formulation (Relugolix/Estradiol/Norethindrone Acetate). The medication is not listed on the FDA Drug Shortage Database.

The primary access barriers are:

• Retail pharmacy stocking: Chain pharmacies prioritize high-volume medications and often don't carry Myfembree in regular inventory
• Cost: Retail price ranges from $1,200 to $1,700/month, making pharmacies cautious about stocking without confirmed demand
• Insurance hurdles: Prior authorization requirements and step therapy policies delay pharmacy dispensing
• Generic distribution: While available, the generic is not yet universally carried by all pharmacies

Why Patients Can't Find Myfembree

When a patient reports they can't find Myfembree, the problem usually falls into one of these categories:

1. The pharmacy doesn't stock it — They need to order it from their wholesaler (1-3 business days)
2. Insurance hasn't approved it yet — Prior authorization is pending, and the pharmacy won't dispense or order until it's resolved
3. The pharmacy can't get it from their wholesaler — Some wholesalers have limited allocation for specialty products
4. The patient's plan requires a specialty pharmacy — The prescription was sent to the wrong pharmacy type

What Providers Can Do: 5 Steps

Step 1: Submit Prior Authorization Early

Don't wait until the prescription is at the pharmacy. Submit prior authorization as soon as you decide to prescribe Myfembree. Many practices now use electronic prior authorization (ePA) tools integrated with their EHR, which can significantly speed up the process.

Include supporting documentation upfront:

• Diagnosis (uterine fibroids with heavy menstrual bleeding, or endometriosis with moderate-to-severe pain)
• Previous treatments tried and their outcomes (for step therapy requirements)
• Clinical rationale for Myfembree specifically (once-daily dosing, integrated add-back therapy)

Step 2: Send Prescriptions to Specialty Pharmacies

Rather than sending Myfembree prescriptions to retail chain pharmacies, identify 1-2 specialty pharmacies in your area (or national mail-order specialty pharmacies) that reliably stock it. Specialty pharmacies are designed to handle high-cost medications and typically offer:

• Consistent inventory of specialty drugs
• Insurance coordination and prior authorization assistance
• Home delivery options
• Patient counseling and adherence support

Building a relationship with a reliable specialty pharmacy can dramatically reduce access issues for your Myfembree patients.

Step 3: Use Medfinder to Check Availability

Medfinder for Providers allows you to check real-time Myfembree availability at pharmacies near your patient's location. You can use this tool during the office visit to:

• Confirm which pharmacies have Myfembree in stock before writing the prescription
• Direct patients to a specific pharmacy where the drug is available
• Reduce patient callbacks about unfilled prescriptions

Consider bookmarking medfinder.com/providers for your front desk or clinical staff to reference when patients ask about availability.

Step 4: Enroll Patients in the Copay Assistance Program

Cost is a major barrier to Myfembree access. Help your patients by informing them about the Myfembree Copay Assistance Program, which allows eligible commercially insured patients to pay as little as $0 per fill. Enrollment is available through the TrialCard portal.

For uninsured or underinsured patients, Myovant Sciences offers a separate Patient Assistance Program. NeedyMeds and RxAssist are additional resources for finding financial assistance.

For a comprehensive patient-facing guide to savings options, share: How to Save Money on Myfembree.

Step 5: Educate Patients on Proactive Refill Management

Advise patients to:

• Request refills 7-10 days before running out
• Confirm with the pharmacy that the medication is in stock or ordered
• Use Medfinder to check availability if their usual pharmacy is out of stock
• Consider the generic formulation if the brand is unavailable

Alternatives to Consider

When Myfembree is unavailable, not covered by insurance, or contraindicated, consider these alternative therapies:

• Oriahnn (Elagolix/Estradiol/Norethindrone Acetate) — Oral GnRH antagonist with add-back; approved for uterine fibroids; twice-daily dosing
• Orilissa (Elagolix) — Oral GnRH antagonist without add-back; approved for endometriosis; available in 150 mg QD and 200 mg BID
• Lupron Depot (Leuprolide Acetate) — Injectable GnRH agonist; approved for both conditions; initial flare; typically short-term with optional add-back

For a detailed comparison to share with patients: Alternatives to Myfembree.

Workflow Tips for Your Practice

Here are some operational strategies to reduce Myfembree access issues across your practice:

• Create a Myfembree prescribing checklist that includes: prior authorization submission, specialty pharmacy selection, copay program enrollment, and patient education materials
• Train front-desk and nursing staff to direct Myfembree-related pharmacy questions to medfinder.com/providers
• Set EHR reminders to follow up on prior authorization status 48-72 hours after submission
• Keep a list of specialty pharmacies that reliably stock Myfembree in your area
• Document insurance denials thoroughly to support appeals — include symptom severity, impact on quality of life, and prior treatment failures

Final Thoughts

Helping patients access Myfembree requires a proactive approach from the prescribing practice. By submitting prior authorizations early, routing prescriptions to specialty pharmacies, leveraging tools like Medfinder for Providers, and connecting patients with financial assistance programs, you can significantly reduce the frustration and treatment delays that many Myfembree patients currently experience.

For a broader overview of the supply and availability landscape, see our companion article: Myfembree Shortage: What Providers and Prescribers Need to Know in 2026.